Cost-effectiveness analysis of the treatment with compressive therapy in the healing of venous ulcers

被引:0
|
作者
Sodre, Sarah Lopes Silva [1 ,2 ,3 ]
Nogueira, Glycia de Almeida [3 ]
de Abreu, Alcione Matos [4 ]
Marta, Cristiano Bertolossi [5 ,6 ]
Peregrino, Antonio Augusto de Freitas [6 ,7 ]
da Silva, Roberto Carlos Lyra [5 ]
机构
[1] Hosp Univ Graffre Guinle, Ctr Terapia Intens, Rio De Janeiro, RJ, Brazil
[2] Hosp Cent Aeronaut, Rio De Janeiro, RJ, Brazil
[3] Univ Fed Estado Rio De Janeiro, Rio De Janeiro, RJ, Brazil
[4] Univ Fed Estado Rio De Janeiro, Dept Enfermagem Med Cirurg, Rio De Janeiro, RJ, Brazil
[5] Univ Estado Rio De Janeiro, Dept Enfermagem Fundamental, Rio De Janeiro, RJ, Brazil
[6] Univ Veiga Almeida, Fac Enfermagem, Rio De Janeiro, RJ, Brazil
[7] Univ Estado Rio De Janeiro, Dept Ciencias Radiol, Rio De Janeiro, RJ, Brazil
来源
REVISTA LATINO-AMERICANA DE ENFERMAGEM | 2023年 / 31卷
关键词
RANDOMIZED CONTROLLED-TRIAL; SHORT-STRETCH; CLINICAL-TRIAL; 4-LAYER; BANDAGES; SYSTEMS;
D O I
10.1590/1518-8345.6017.3840
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective: to analyze the cost-effectiveness and calculate the incremental cost-effectiveness ratio of multilayer compressive treatment in relation to inelastic (Unna boot and short stretch) therapy according to the current literature. Method: quantitative study about cost-effectiveness through modeling with the aid of TreeAge (R) software for construction of the decision tree. The anticipated assumptions were obtained by using secondary literature data to estimate the cost and effectiveness of the assumed parameters. A systematic literature review with meta-analysis was performed for this end. Results: the decision tree after Roll Back showed that the multilayer therapy dominated the alternatives in the base case, representing an intermediate cost per application, although with the highest effectiveness. The cost-effectiveness analysis graph also showed extended dominance of the Unna boot in relation to the short stretch bandage. The sensitivity analysis showed that multilayer bandage remains a more cost-effective alternative, within the threshold of willingness to pay. Conclusion: the most cost-effective alternative was multilayer bandage, considered the gold standard in the literature. The second most cost-effective alternative was the Unna boot, the most used therapy in Brazil. Descriptors: Varicose Ulcer; Leg Ulcer; Compression Bandages; Bandages; Wound Healing; Technology Assessment, Biomedical.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Cost-effectiveness of adjunctive hyperbaric oxygen in the treatment of diabetic ulcers
    Guo, S
    Counte, MA
    Gillespie, KN
    Schmitz, H
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2003, 19 (04) : 731 - 737
  • [22] Cost-effectiveness of Dermagraft® for the treatment of diabetic foot ulcers in France
    Allenet, B
    Parée, F
    Possnett, J
    Carr, L
    Van, GH
    Malgrange, D
    Michon, P
    Martini, J
    Pradines, S
    Race, A
    Richard, JL
    Tsiritsikolou, D
    DIABETOLOGIA, 1999, 42 : A308 - A308
  • [23] Relative cost-effectiveness of a skin protectant in managing venous leg ulcers in the UK
    Guest, J. F.
    Taylor, R. R.
    Vowden, K.
    Vowden, P.
    JOURNAL OF WOUND CARE, 2012, 21 (08) : 389 - +
  • [24] COST-EFFECTIVENESS ANALYSIS OF THE THERAPY OF ENDOMETRIOSIS
    Tuletova, A.
    Dochshanova, A.
    Skakova, R.
    VALUE IN HEALTH, 2014, 17 (07) : A511 - A511
  • [25] TO STUDY THE ROLE OF COMPRESSIVE THERAPY AND SURGICAL INTERVENTION IN TREATMENT OF VENOUS ULCERS
    Walling, Sashi T.
    Vinod, K.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2015, 4 (61): : 10697 - 10703
  • [26] Effectiveness of dressings for healing venous leg ulcers
    Lopez, Pablo
    Dachs, Robert
    AMERICAN FAMILY PHYSICIAN, 2007, 75 (05) : 649 - 650
  • [27] COST-EFFECTIVENESS ANALYSIS FOR APIXABAN IN THE ACUTE TREATMENT AND PREVENTION OF VENOUS THROMBOEMBOLISM IN THE NETHERLANDS
    De Jong, L.
    Dvortsin, E. P.
    Janssen, K. J.
    Postma, M. J.
    VALUE IN HEALTH, 2016, 19 (07) : A651 - A651
  • [28] Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands
    Stevanovic, J.
    de Jong, L. A.
    Kappelhoff, B. S.
    Dvortsin, E. P.
    Voorhaar, M.
    Postma, M. J.
    PLOS ONE, 2016, 11 (10):
  • [29] COST-EFFECTIVENESS ANALYSIS OF APIXABAN AND RIVAROXABAN FOR TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM IN CHINA
    Gu, X.
    Wu, B.
    VALUE IN HEALTH, 2017, 20 (09) : A618 - A618
  • [30] Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands
    Heisen, Marieke
    Treur, Maarten J.
    Heemstra, Harald E.
    Giesen, Eric B. W.
    Postma, Maarten J.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (08) : 813 - 824